Clinical Trials Browser

Active not recruiting × Hematologic Neoplasms × atezolizumab × Clear all

NCT02862275 2025-10-23

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Phase 1 Active not recruiting

Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms